Dr Merit Cudkowicz most recently stated in the Healey platform webinar that they’re planning on initiating the next regimens Q4 of 24 to Q1 of 25. They are negotiating with the FDA on updating the trial design. I suspect that this may be part of the reason for silence on when phase 2 trial start date is planned to initiate.
Corporate action, page-234
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $87.89M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.0¢ | 19.5¢ | $67.12K | 339.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 420397 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 109318 | 6 |
View Market Depth
| Last trade - 15.36pm 09/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |